4
Changes in Ownership
RxSight, Inc. Filed Acc 0001209191-23-060012
President & CEO sold 22,500 shares at $41.09 ($924,498)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
RxSight, Inc. Filed Acc 0001209191-23-060012
President & CEO sold 22,500 shares at $41.09 ($924,498)
From the SEC's structured data for this filing
Connection lost
Reconnecting…
Cite Filings isn't responding
Reconnecting…